Get startedLog in
    Picture of Takeda Pharmaceutical logo

    4502 — Takeda Pharmaceutical News Story

    0.000.00%
    jp flag iconLast trade - 00:00
    HealthcareConservativeLarge CapMomentum Trap
    All News

    Brief: British Columbia Reimburses Revestive® (Teduglutide For Injection) For The Treatment Of Short Bowel Syndrome

    Picture of Takeda Pharmaceutical logoTakeda Pharmaceutical
    05/05/2026 13:32
    May 5 (Reuters) - Takeda Pharmaceutical Co Ltd 4502.T:

BRITISH COLUMBIA REIMBURSES REVESTIVE® (TEDUGLUTIDE FOR INJECTION) FOR THE TREATMENT OF SHORT BOWEL SYNDROME

Source text: ID:nCNW9zCmwa

Further company coverage: 4502.T

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Takeda Pharmaceutical

    See all news